One of the newer treatments being explored for managing chronic conditions, including colitis, is semaglutide
Building upon these findings, Zhao et al
Mounjaro (tirzepatide for T2DM) and Zepbound (tirzepatide for obesity) from Eli Lilly are growing at the fastest CAGR, driven by the dual GLP-1/GIP receptor agonist mechanism that has consistently demonstrated superior weight loss outcomes versus semaglutide in head-to-head clinical comparisons
Patients with a history of pancreatitis, particularly those with chronic pancreatitis or recurrent acute episodes, may be at increased risk for pancreatitis recurrence or exacerbation
In-Depth Assessments Reviewing medical history, occupational exposure, and lifestyle risk factors Functional lab testing to detect metal concentrations in blood, urine, hair, or stool Testing detox pathway efficiency, nutritional status, and inflammation markers 2
Massaging could cause discomfort, swelling or even bruising and can increase the chance of the medication being quickly metabolised